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Abstract.  The expression of platelet-derived growth 
factor (PDGF) receptors in porcine uterus and human 
skin in situ, was compared with that of cultured pri- 
mary cells isolated from the same tissues.  PDGF re- 
ceptor expression was examined by monoclonal anti- 
bodies specific  for the B type PDGF receptor and by 
RNA/RNA in situ hybridization with a probe con- 
structed from a cDNA clone encoding the B type 
PDGF receptor.  In porcine uterus tissue both mRNA 
and the protein product for the PDGF receptor were 
detected in the endometrium; the myometrium, in con- 
trast, contained much lower amounts. Moreover, 
freshly isolated myometrial cells were devoid of PDGF 
receptors.  However,  after 1 d in culture receptors ap- 
peared, and after 2 wk of culturing essentially all of 
the myometrial cells  stained  positively with the anti- 
PDGF receptor antibodies and contained PDGF recep- 
tor mRNA. Similarly, B type PDGF receptors were 
not detected in normal human skin, but fibroblast-like 
cells from explant cultures of human skin possessed 
PDGF receptors.  When determined by immunoblot- 
ting, porcine uterus myometrial membranes contained 
",,20 % of the PDGF receptor antigen compared with 
the amount found in endometrial membranes. In ad- 
dition, PDGF stimulated the phosphorylation of a 
175-kD component, most likely representing autophos- 
phorylation of the B type PDGF receptor in endo- 
metrial membranes, whereas only a marginal phos- 
phorylation was seen in myometrial membranes. Taken 
together,  these results demonstrate that PDGF receptor 
expression varies  in normal tissues and that fibroblasts 
and smooth muscle cells do not uniformly express the 
receptor in situ. Furthermore, fibroblasts  and smooth 
muscle cells that are released from tissues are induced 
to express  PDGF receptors in response to cell cultur- 
ing.  The data suggest  that, in addition to the availabil- 
ity of the ligand, PDGF-mediated cell growth in vivo 
is dependent on factors regulating expression of the 
receptor. 
p 
eArELET-derived growth factor (PDGF) ~ is a major 
mitogen  in  serum  for cultured  mesenchymal  cells. 
PDGF is a cationic protein of 30 kD which consists 
of two polypeptide chains, denoted A and B, interconnected 
by disulfide bridges (see references 18 and 34 for reviews). 
The two polypeptide chains are ,o60%  homologous to each 
other, and can be combined as homo- or heterodimers. Thus, 
three dimeric  forms of PDGF exist,  PDGF-AA,  -AB, and 
-BB, with different functional activities. This is probably due 
to different specificities in binding to two distinct  PDGF 
receptor classes, denoted type A and type B, that are present 
on the cell surface of responsive cells (14, 20,  30). 
The A type PDGF receptor, which binds all dimeric forms 
of PDGF, has not been characterized.  The B type receptor, 
1. Abbreviations used in this paper: PDGE platelet-derived growth factor; 
PS, streptomycin. 
which binds PDGF-BB and, with lower affinity, PDGF-AB, 
has been purified as a 170-185-kD component (1, 8, 32) with 
a protein tyrosine kinase activity associated with its cytoplas- 
mic domain (reviewed in reference 15). The B type receptor 
seems to be responsible for a major part of the mitogenic 
effect of PDGF-like factors on human fibroblasts (20). The 
amino acid sequence of this receptor has been deduced from 
cDNA clones (5, 13, 38) and shows homology to other tyro- 
sine kinases, especially those encoded by the protooncogene 
c-kit (39) and the receptor for colony stimulating factor-1 (7). 
Binding of  PDGF to the receptor activates the tyrosine kinase 
domain and leads to enhanced phosphorylation of intracellu- 
lar substrates (6, 9, 11, 27), as well as to autophosphorylation 
of the receptor  (9-11, 29, 31). 
The demonstration of high affinity receptors for PDGF, 
through use of ~zsI-labeled PDGF have been limited to cul- 
tured cells of connective tissue origin  (16). These include 
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glial  cells,  and  chondrocytes  (reviewed  in  reference  3). 
Studies on the expression of PDGF receptors in vivo have 
been hindered by the lack of an appropriate method to iden- 
tify PDGF receptors in tissues. Consequently it is not known 
on which cell types, or under what conditions, PDGF recep- 
tors  are  expressed  in  the  intact  organism.  Recently,  we 
reported  the  development  of mAbs  to  the  B  type  PDGF 
receptor isolated from porcine uterus (33). These antibodies 
have been shown to recognize the external domain of the B 
type PDGF receptor in cultured cells (33), and to be useful 
for immunohistochemical detection of the receptor in rheu- 
matoid arthritic synovium (35). In these initial studies it was 
observed that the B type PDGF receptor was not detectable 
in the synovium of healthy subjects, but was induced in con- 
junction with inflammation. In this report, we show, by use 
of immunohistochemical staining and in situ hybridization, 
that B type PDGF receptors are present at very low or unde- 
tectable levels in normal human dermis and porcine myo- 
metrium and  that the  level of functional  receptor rises as 
cells isolated from these tissues are propagated in culture. 
Materials and Methods 
1issues 
Swine uterus was obtained from a meat packing plant immediately after the 
death of the animal. Human skin was obtained from healthy subjects under- 
going elective mammary plastic surgery. Biopsies of both tissues were taken 
and immediately frozen in liquid isopentane at -150°C and stored at -70°C 
until cryosectioned (25).  The remainder of the tissue was used for tissue 
culture experiments (see below). 
Cell Isolation  and Tissue Culture 
Smooth Muscle Cells.  Swine uterus was transported to the laboratory in 
PBS containing 100 U/ml penicillin,  100 p.g/ml  streptomycin (PS) on ice. 
The outer layer of smooth muscle was stripped from the uterus and minced 
into small pieces (1 ram3).  Similarly, endometrial folds were cut free with 
scissors and minced into small pieces. The minced tissues were digested 
with 800 U/ml collagenase type I and DNase type II (Sigma Chemical Co., 
St. Louis, MO), dissolved in DME containing 10% FBS and PS for 30 min 
at 37°C on a  reciprocating shaker. After 30 min the dislodged cells were 
harvested, washed with DME-FBS-PS, resuspended in the same medium, 
and stored on ice for further use. Fresh enzyme was added to the undigested 
tissue and the digestion continued for 30 rain. The cycle of digestion and 
harvesting was repeated at least five times. The isolated cells were filtered 
through 125-~m mesh nylon screen and plated on 22  x  22-ram fibronectin- 
coated coverslips for immunofluorescence, on 76 ×  26-mm glass slides for 
in situ hybridization, or T-25 flasks (Falcon Labware, Oxnard, CA) for long 
term culture in DME-FBS-PS. The cultures were fed every other day with 
fresh DME-FBS-PS. 
Human Skin Fibroblasts.  Small pieces of dermis (1-2 mm  3) were ex- 
planted to 60-mm culture dishes (Corning Glass Works, Coming, NY) and 
fed with DME-FBS-PS.  After 7-10 d  in culture, outgrown fibroblast-like 
cells were harvested with 0.1% trypsin, 0.1% EDTA in PBS and plated onto 
22  x  22-mm  2 coverslips, glass microscope slides, or into T-25 flasks and 
fed with DME-FBS-PS. 
Antibodies 
The characteristics and specificity of the two mouse mAbs against the B type 
PDGF receptor (PDGFR-B1, PDGFR-B2) used in this study have been de- 
scribed previously (33). PDGFR-B2 does not recognize the human A type 
PDGF receptor (20). The rabbit polyclonal antisera, PDGFR-1, was made 
against purified  porcine uterus PDGF  receptor (32),  and PDGFR-3  was 
made against amino acids 981-984 of the mouse receptor sequence (38). 
PDGFR-3  specifically  recognizes  PDGF  B  type  receptors,  whereas 
PDGFR-1 recognizes both A and B type PDGF receptors (5a). The muscle 
specific actin mAb (HHF-35) was from Enzo Biochemical, Inc. (New York, 
NY) and a  mAb specifically recognizing vimentin intermediate filaments 
from Labsystems (Helsinki, Finland). 
lmmunohistochemical Staining Procedure 
Frozen sections from swine uterus and human skin biopsies were prepared 
as previously described (25). Briefly,  the sections were fixed in acetone, ex- 
haustexi of endogenous peroxidase and subsequently subjected to immuno- 
histochemical staining using mAbs and the ABC-technique (22, 23). Con- 
trol stainings were performed with an irrelevant parathyroid reactive mAb 
(24) of the same isotype and originating from the same mouse strain as the 
PDGFR-BI  antibody,  or  by  omitting the respective primary  antibodies. 
Control stainings were always negative. 
Immunofluorescence Staining for B 1~pe 
PDGF Receptors 
Coverslips with cultured cells or freshly adhered cells were washed three 
times for 5 min each with DME and incubated for 60 min at 4°C with 50 
~tg/ml of receptor mAb PDGFR-B2 in DME. The coverslips were washed 
three times for 5 min each with DME and then incubated with 1:50 dilution 
of FITC-labeled goat-anti-mouse IgG in DME for 60 min at 4°C.  After 
washing as above,  the coverslips were  mounted on  slides in  DME  and 
viewed immediately in a Nikon microscope equipped with epifluorescence. 
The slides were kept at 4°C before viewing and photography, then warmed 
to 37°C for 30 min and examined and photographed again. Control experi- 
ments included the following: (a) substitution of unrelated mAbs for PDGF 
receptor antibody PDGFR-B2, (b) substitution of PBS for antibodies, and 
(c) down-regulation of PDGF receptors by preincubation of cells with 150 
ng/ml of PDGF (purified from human platelets as described [19] and con- 
taining 70% PDGF-AB and 30% PDGF-BB) for 30 min at 37°C before incu- 
bation with PDGF receptor monoclonals. Previously we have demonstrated 
the efficiency of the absorption of the PDGF receptor monoclonal PDGFR- 
B2 with an excess of B type PDGF receptor before use (33). 
In Situ Hybridization 
Slide Preparation.  Glass microscope slides were washed in water and then 
in 96% ethanol, dried,  and autoclaved two times before use for culturing 
of cells. The cultured cells were washed three times with PBS before fixa- 
tion. Cryostat sections (6 p.m) were mounted on slides previously coated 
with 100 txg/ml of poly-L-lysine (Sigma Chemical Co.) and allowed to air 
dry for 5 min. The cultured cells and sections were then fixed in 4% parafor- 
maldehyde in PBS for 5 min and stored until used in 70%  ethanol. 
Construction  and Labeling of Probe for In Situ Hybridization.  A Pst 
I fragment of a eDNA corresponding to the aminoterminal part of the B type 
human PDGF receptor (5) was subcloned into p GEM blue (Promega Bio- 
tec, Madison, Wl) linearized, and used as a template for RNA probe.  In 
a control experiment on endothelial cells, a 2.7-kb Bam HI fragment of a 
human PDGF B-chain eDNA originating from a glioma cell line and cover- 
ing the whole translated sequence, the whole 3' untranslated sequence, and 
part of the 5' untranslated sequence. The 35S-labeled probe was transcribed 
in vitro using the T7 promotor, as previously described (12). 
Hybridization.  In situ hybridization was performed essentially as de- 
scribed before (12). 20 I.tl of the probe mixture (0.5-1  ng labeled RNA probe 
in 50% formamide, 10% dextran, 10 mM dithiotreitol [DTT],  1 mg/ml E. 
coli tRNA,  1 mg/ml sheared herring sperm DNA, 2 mg/ml nuclease-free 
BSA in 2x SSC) (Ix SSC is 0.15 M NaCI/7.5 mM sodium citrate) was used 
to hybridize the cells or cryostat tissue sections. Hybridization was carried 
out for 3 h at 52°C. 
The hybridization signals were detected by autoradiography using liquid 
emulsion (NTB-2, Eastman Kodak Co., Rochester, NY), as described (12). 
The  slides  of cultured  cells  were  either  stained  with  May-Griinewald- 
Giemsa or viewed with phase-contrast objectives. The tissue sections were 
stained with hematoxylin and eosin. 
Controls included cells positive and negative for PDGF receptor (human 
foreskin  fibroblasts  type  AG1523;  American  Type  Culture  Collection, 
Rockville, MD) and porcine aortic endothelial cells, respectively, pretreat- 
ment of the slides with RNase before hybridization, the use of a  35S-la- 
beled sense-strand RNA probe transcribed from a human B-chain eDNA 
containing plasmid, and competition with an excess of nonradioactive anti- 
sense PDGF-receptor probe. 
Quantitation  of Silver Grains.  The density of silver grains in the au- 
toradiograms was determined by an Image-l/AT Digital Image Processing 
System (Universal Image Corp., Ithaca, NY) interfaced with a MTI SIT 66 
The Journal of Cell Biology,  Volume 107,  1988  1948 Figure  1.  Distribution of B type PDGF receptor  in various parts of porcine uterus as detected by immunohistochemical staining.  (a) A 
section of endometrium stained with PDGFR-B2 antibodies (50 lag/mL) showing the golden brown reaction product indicative of B type 
PDGF receptor on the stromal cells surrounding  an endometrial gland (arrows). The stromal cells of the loose connective  tissue also contain 
some reaction product as do the walls of small blood vessels (bv).  (b) A higher magnification of an endometrial blood vessel (analogous 
to the coiled arteries in the humans) showing reaction product in the wall of the blood vessel. Scattered stromal cells also contain reaction 
product of the B type PDGF receptor. (c) A section of myometrium and larger blood vessel (bv) showing the lack of B type PDGF receptor 
staining in the wall of the blood vessel and in the myometrial  smooth muscle.  (d) Myometrium from an actively growing pig (8 wk of 
age) showing reaction product on what appears  to be myometrial  smooth muscle cells.  Bars,  10 p.m. 
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tion of B type PDGF receptors 
in  membrane  preparations. 
Membranes prepared from por- 
cine uterus myometrium (lanes 
A  and  B)  and  endometrium 
(lanes Cand D) were incubated 
with [32p]ATP in the absence 
(lanes B  and  D)  or presence 
(lanes  A  and  C)  of  PDGF. 
Samples  were  analyzed  by 
SDS-gel  electrophoresis  and 
autoradiography. 
Figure 2. Quantitative determination of PDGF receptor amounts in 
porcine  uterus  myometrial and  endometrial  membranes.  Crude 
membrane proteins in serial dilutions from the two regions of the 
uterus  were  subjected  to  immunoblotting  using  a  rabbit  PDGF 
receptor polyclonal antiserum (PDGFR-1).  Bound rabbit IgG was 
detected by incubation with goat anti-rabbit IgG conjugated to alka- 
line phosphatase. (Lanes A-E) Myometrial membranes; and (lanes 
F-J) endometrial membranes. (Lanes A and F) 100 Ixg protein; (B 
and  G)  30;  (C and H)  10;  (D and I)  3;  and (E and J)  1  lag. 
Video Camera (DAGE-MTI,  Inc.  Michigan City,  IN) and a photomicro- 
scope (model IM-35; Carl Zeiss, Inc., Thornwood, NY) using the proce- 
dure recommended by the manufacturer. Briefly, digital images of the au- 
toradiograms are captured with the SIT camera and stored in the computer. 
Intensity levels were set so that the size and density of  the silver grains could 
be detected and the number of silver grains per unit area was determined. 
Background  levels of silver grains on control slides (nonsense probe or 
RNase pretreatment) were subtracted from the density found on the ex- 
perimental slides. Data was expressed as silver grains/100 i.tm  2 +  SEM. 
Preparation of  Membranes 
Preparation of membranes from swine endometrial and myometrial tissues 
were done essentially as described (32). Membranes were stored at -20°C 
in 20 mM Hepes,  1 mM EGTA,  1 mM DTT,  pH 7.4,  before use. 
Autophosphorylation Assay 
Membranes (l mg) from each source were solubilized in 2.5% (vol/vol) Tri- 
ton X-100,  10%  (vol/vol) glycerol, 20 mM Hepes,  1 mM EGTA,  1 mM 
DTT, pH 7.4, in a total volume of 500 t.tl, on ice for 30 rain. The solubilizate 
was then spun in an Eppendorf Microfuge at 14,000 rpm for 10 min. The 
supernatant was incubated in 50-ktl  aliquots with 3  mM MnCI2,  25  I.tM 
Na3VO4, in the presence or absence of 2.5 p.g/ml of PDGF for 10 min on 
ice. The kinase reaction was initiated by addition of 15 p.M [32p]ATP (5  × 
106 dpm). After 10 min on ice, the kinase reaction was stopped by adding 
15 mM ATP and 40 mM phenylpbosphate. The samples were given 3 Ixl 
of rabbit anti-PDGF receptor antiserum (PDGFR-I) and incubated for 2 h 
on ice. Subsequently 50 p.l of  a 1:1 slurry of  Protein A-Sepharose was added 
and the samples were incubated for 30 min on ice with occasional shaking 
of the tubes. At the end of the incubation, the beads were spun down and 
washed five times with 1% (vol/vol) Triton X-100, 1% (wt/vol) sodium deox- 
ycholate, 0.15 M NaCI, 20 mM Hepes, 10 mM NaF,  10 mM EDTA, 30 mM 
NaaP207,  pH 7.4,  once with 0.2%  (vol/vol) Triton X-100,  10%  (vol/vol) 
glycerol, 1 mM EGTA, 0.5  M  NaCl, 20 mM Hepes, pH 7.4,  and finally 
with 20 mM Hepes, pH 7.4. The beads were then heated at 95°C for 3 min 
in the presence of 50 lal of reducing SDS-sample buffer, alkylated, and sub- 
jected to PAGE in SDS using a 5-10% gradient gel and the buffer system 
described by Blobel and Dohberstein (2). 
Immunoblotting 
Membranes from the tissues and cultured cells were subjected to SDS-gel 
electrophoresis, using a 5-10% gradient gel (2).  After electrophoresis, pro- 
teins were electrophoretically transferred to nitrocellulose sheets (mem- 
brane filters, BA 83, 0.2 I.tm, Schleicher & Schuell, Dassel, BRD), as de- 
scribed  (4).  After  transfer,  the  nitrocellulose  papers  were  blocked  by 
incubation in 5% BSA, 0.15 M NaCl, 0.01 M Tris-HCl, pH 7.4, overnight 
at 4°C. The sheets were incubated with PDGF receptor antisera (PDGFR-I 
or PDGFR-3; diluted 1:50 in the blocking buffer) for 1 h at room tempera- 
ture. The blots were washed twice for 5 min in 0.15 M NaCl, 0.01 M Tris, 
pH 7.4,  twice in the same buffer supplemented with 0.05%  Triton X-100, 
and finally three times for 5 min with Triton-free wash buffer. The blots were 
incubated for 30 min with a  1:1,000 dilution of alkaline phosphatase-con- 
jugated swine anti-rabbit immunoglobulins (DAKOPATS, Glostrup,  Den- 
mark) and a  1:1,000 dilution of alkaline phosphatase conjugated to avidin 
(DAKOPATS) in 0.1% BSA, 0.15 M NaCl, 0.01 M Tris-HCI, pH 7.4.  The 
blots were washed as above and developed using a  5-bromo-4-chloro-3- 
indolyl phosphate (Sigma Chemical Co.) as substrate (22). Biotinylated mo- 
lecular  weight  standards  were  visualized  after  incubation  with  alkaline 
phosphatase conjugated to avidin and developed as above. 
Results 
Immunohistochemical Staining of  Frozen Sections 
Porcine uterus has been identified as a rich source of PDGF 
receptor (32).  Staining  of sections of adult porcine uterus 
with  PDGFR-B1  and  PDGFR-B2  antibodies  demonstrated 
that the immunoreactivity was principally located on stromal 
cells adjacent to the endometrial glands (Fig.  1, a  and b). 
Small blood vessels (analogous to coiled arteries in human) 
located deeper in the endometrium were also positive with 
these antibodies (Fig.  1, a and b). The smooth muscle layers 
and  surrounding  connective tissue of the  myometrium did 
The Journal  of Cell Biology,  Volume 107, 1988  1950 Figure 4.  Immunofluorescence staining with PDGFR-B2 antibodies on myometrial and endometrial cells in culture.  Cells were isolated 
by collagenase treatment from porcine myometrial (a, c-i) and endometrial (b) tissue and stained with PDGFR-B2 antibodies directly 
after isolation (a and b), after 10 (c),  18 (d), 24 (e), 48 (f), and 72 h in culture (g).  Myometrial cells cultured for 72 h and 98 h, were 
also treated with 150 ng/mL of PDGF-AB before staining with PDGFR-B2 (h), and stained with muscle-specific anti-actin antibody (i), 
respectively. Bar,  10 I.tm. 
not stain  for B  type PDGF  receptor (Fig.  1 c),  neither did 
smooth  muscle in the tunica media of larger blood vessels 
(Fig.  1 c). This is a notable finding since smooth muscle cells 
grown in vitro have been found to possess PDGF  receptors 
(3,  16).  Similarly,  sections  of dermis  from normal  human 
skin  (see  below,  Fig.  5  a)  did  not  stain  with  anti-PDGF 
receptor  mAbs  in  spite  of the  fact that  fibroblasts  in  vitro 
have  PDGF  receptors.  However,  uterus  from  an  actively 
growing pig (8 wk of age) demonstrated staining on both en- 
dometrial stromal cells (not shown) and myometrial smooth 
muscle  (Fig.  1 d). 
Analysis by Immunoblotting 
Immunoblotting of membranes isolated from the outer mus- 
Terracio et al. Induction of PDGF  Receptor Expression  1951 Figure 5. Expression of B type PDGF receptors in human skin and skin fibroblasts as determined by staining with the PDGFR-B2 antibody 
and in situ hybridization.  (a) Immunohistochemical staining of human dermis; note that no PDGF receptor staining is seen anywhere in 
the tissue. (b) In situ hybridization with the PDGF receptor probe on human dermis; no B type PDGF receptor mRNA is seen.  (c) Phase 
contrast micrograph of cells grown from skin explants; cells have a typical fibroblast-like morphology. (d) In situ hybridization on human 
skin fibroblast culture (same as in c) with an mRNA probe for the B type PDGF receptor-positive hybridization is seen on the cells. 
The Journal of Cell Biology, Volume 107, 1988  1952 Figure 6.  In situ hybridization of B type PDGF receptor mRNA in sections  of porcine uterus  endometrium.  (a) Endometrium showing 
a heavy deposition of silver grains indicative  of B type PDGF receptor mRNA over the stromal  cells surrounding an endometrial  gland. 
(b) Serial  section hybridized with a "nonsense" probe showing the background levels of silver grains.  (c) A high magnification  of a blood 
vessel  (similar  to Fig.  1 b) hybridized with the B type PDGF receptor mRNA probe. Numerous silver grains can be seen over the wall 
of the blood vessel indicating  the presence of receptor mRNA. (d) A similar section to that seen in c of a blood vessel hybridized  with 
a "nonsense"  probe showing  background level of silver  grains.  Bars,  10 lain. 
cle  layer  and  endometrium  of  swine  uterus  and  human 
dermis  supported  the  histochemical  stainings.  A  rabbit 
anti-PDGF receptor serum, PDGFR-1, recognized a 175-kD 
PDGF receptor in endometrial membranes (Fig. 2), as well 
as  in  human  dermis  (not  shown).  The  concentration  was 
about five times  higher in endometrial  than  in myometrial 
membranes when normalized per mg of membrane proteins 
(Fig. 2). A very similar result was obtained when antiserum 
PDGFR-3  recognizing  only  B-type  PDGF  receptors,  was 
used (not shown). Immunoblots of membranes from cultured 
myometrial  smooth  muscle  cells  and  fibroblasts  indicated 
that PDGF receptors are present on these cells (not shown). 
Autophosphorylation Assay 
The presence of functional B type PDGF receptors in mem- 
branes  prepared  from  porcine  myometrium  and  endome- 
trium and human dermis,  as well as from cultured porcine 
smooth muscle cells and dermal fibroblasts,  were examined 
by use of a phosphorylation assay. In membranes from por- 
cine endometrium (Fig.  3),  as well as from cultured fibro- 
blasts and smooth muscle cells (not shown),  PDGF stimu- 
lated  the  phosphorylation  of a  175-kD  band,  most  likely 
representing  autophosphorylation  of  the  PDGF  receptor 
(10).  In  contrast,  only  a  limited  PDGF-stimulated  phos- 
phorylation was  noticed  in  membrane  from porcine  myo- 
(e) Immunofluorescence staining of a replicate culture of human skin fibroblasts with PDGFR-B2 antibodies;  PDGF receptors  are demon- 
strated as bright fluorescent  punctate areas.  (f) A replicate  culture of human skin fibroblasts incubated  with 150 ng/ml of PDGF to down- 
regulate  PDGF receptors,  before staining  with PDGFR-B2 antibodies;  no staining  is seen.  Bars,  10 I.tm. 
Terracio et al. Induction of PDGF  Receptor Expression  1953 Figure 7. In situ hybridization of B type PDGF receptor mRNA in myometrium and cultured cells. (a) Myometrium,  showing a low but 
uniform level of hybridization.  (b) Myometrial cells directly after isolation, showing background levels of labeling. (c) Myometrial cells 
after 7 days in culture, demonstrating heavy labeling. (d) Cultures of endothelial cells known to be devoided of PDGF-B receptors, few 
or no silver grains are seen.  Bars,  10 ~m. 
metrium (Fig. 3) and human dermis (not shown). These data 
support the results of immunohistochemistry and immuno- 
blotting, and indicate that the PDGF receptors recognized by 
the antibodies are functionally active. 
lmmunofluorescence of CeUs Progressing into Culture 
Since smooth muscle cells of uterus myometrium appeared 
not to contain detectable levels of the B type PDGF recep- 
tors, while smooth muscle cells in tissue culture have PDGF 
receptors, experiments were designed to follow the kinetics 
of induction of PDGF receptors as cells progress into cul- 
ture. Cells freshly isolated by collagenase digestion of swine 
uterus myometrium appeared to be essentially devoid of B 
type PDGF receptor as demonstrated by staining  with the 
receptor-specific mAb PDGFR-B2 (Fig. 4 a). The receptor 
appeared to be absent or at low levels also after 10 h in vitro 
(Fig. 4  c), but after 18 h  it started to appear on a few cells 
(Fig.  4  d).  By 24-48  h  a  majority of cells possessed the 
receptor (Figs. 4,  e and f), and by 3 d essentially all cells 
in culture possessed B type PDGF receptors (Fig. 4 g). The 
receptors on these cells could be down-regulated by prior ex- 
posure to PDGF (Fig. 4 h). The isolated cells were identified 
as smooth muscle cells by staining with a muscle-specific ac- 
tin mAb (HHF-35). More than 90% of the freshly isolated 
cells were positive (not shown) and essentially all the cells 
in  culture  at  3  d  possessed HHF-35  positive stress  fibers 
(Fig.  4  i). 
Cells isolated from porcine endometrium were composed 
of fibroblast-like stromal ceils and glandular epithelial cells. 
The stromal cells were positive for B type PDGF receptors 
immediately after isolation and attachment (Fig. 4  b).  The 
epithelial cells were negative immediately after isolation and 
remained negative even in long term culture (21 d, data not 
shown).  The  patched  receptor  stain  seen  on  endometrial 
stromal cells directly after their isolation could be eliminated 
by incubation with PDGF which down-regulates the receptor 
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in culture and were distinctly fibroblastoid in appearance. 
The cells were negative with the muscle-specific actin anti- 
body HHF-35 but possessed vimentin intermediate filaments 
(not shown). 
Cells established from human skin by explant culture ap- 
peared to be fibroblasts, since they displayed fibroblast-like 
growth patterns (Fig.  5  c) and vimentin intermediate fila- 
ments, but not muscle-specific actin (not shown). These cells 
exhibited patched receptors when stained with PDGFR-B2 
(Fig. 5 e), which were eliminated by down-regulation with 
PDGF before staining with PDGFR-B2 (Fig. 5 f). 
In Situ Hybridization 
This distribution of B type PDGF receptor mRNA in tissue 
sections and in cultured cells was determined by in situ hy- 
bridization techniques using a human B type PDGF receptor 
probe. The results were fully compatible with those obtained 
by immunohistochemistry. Silver grains, indicating hybrid- 
ization of the probe with mRNA, were preferentially located 
over stromal cells surrounding glands  (Fig.  6 a),  and fre- 
quently over small blood vessels in the endometrium (Fig. 
6 c). The degree of labeling was much higher than the back- 
ground hybridization with the irrelevant probe (Fig. 6, b and 
d). In contrast, there was a weak uniform distribution of sil- 
ver grains over the myometrium (Fig. 7 a), which was only 
slightly heavier than the background seen with the irrelevant 
probe (not shown). Quantitation of silver grain density with 
background levels subtracted (Fig. 8) indicates that there is 
a 25-fold greater number of silver grains over labeled areas 
in the endometrium than in the myometrium. Although the 
levels seen  in  myometrium are  low  they are  above back- 
ground levels. Similarly, the B type PDGF receptor probe 
only marginally labeled normal human dermis, in agreement 
with the immunohistochemical results using the PDGFR-B2 
antibodies (Fig. 5, a and b). RNAse pretreatment of the sec- 
tions or competition with nonradioactive probe eliminated 
the specific hybridization signal (not shown). 
Freshly isolated cells from porcine uterus myometrium did 
not show any significant labeling (Fig. 7 b). However, cells 
cultured for 7 d demonstrated significant labeling (Fig. 7 c). 
Cultured endothelial cells,  which do not bind [125I]PDGF- 
AB (not shown), were not stained by silver grains indicating 
that they did not express the B type PDGF receptor mRNA 
(Fig.  7  d).  Endothelial cells prepared and handled at the 
same time did hybridize with a probe to the B chain of PDGF 
(not shown), indicating that the processing procedures did 
preserve mRNA detectable by in situ hybridization. 
Discussion 
The results of this study indicate that cells in nonproliferating 
adult tissues, exemplified by porcine myometrial uterus and 
human dermis, possess low levels of B type PDGF receptors. 
This is based on the observed lack of histochemically detect- 
able B  type PDGF receptors on vascular and myometrial 
smooth muscle cells in uterus, as well as on dermal fibro- 
blasts in skin. Similar results were obtained with in situ hy- 
bridization for B type PDGF receptor mRNA. By contrast, 
using  the  same  techniques,  high  levels of B  type PDGF 
receptors were detected on stromal cells in the endometrium. 
The results obtained using the cytochemical techniques were 
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Figure 8.  A graphic representation of 
silver grain density over labeled areas in 
the swine uterus endometrium (E) and 
myometrium (M). The in situ hybridiza- 
tion  with  the  PDGF-B  type  receptor 
probe and  the  Digital Image Analysis 
were performed as described in Materi- 
als and Methods. The background levels 
of silver grains present using an irrele- 
vant probe have been subtracted. Data 
shown is  +  SEM. 
corroborated by a  functional assay  for the  B  type PDGF 
receptor;  PDGF  stimulated  the  autophosphorylation of a 
175-kD receptor protein in solubilized membranes isolated 
from the endometrium but to a much lesser extent in mem- 
branes from the myometrium. In addition, immunoblot anal- 
ysis revealed about a  fivefold difference in B  type PDGF 
receptor  amounts  in  membranes  isolated  from  the  two 
regions of uterus. Whether the presence of a low amount of 
receptors in the myometrial membranes is due to a small con- 
tamination  of  endometrial  membranes  (it  is  technically 
difficult to dissect myometrium and endometrium from each 
other during preparation), or indicates a low expression of 
B type PDGF receptor also in cells of the myometrium, re- 
mains to be elucidated. Of particular interest was the staining 
of stromal  cells  adjacent  to  the  proliferating endometrial 
glands.  As expected, there was no B type PDGF receptor 
staining on the epithelial cells in the glands.  However, the 
dense accumulation of staining on fibroblast-like cells sur- 
rounding the growing end of the glands suggests the possibil- 
ity of stimulation or direction of glandular growth by the 
PDGF receptor-bearing cells. The mechanism of regulation 
of PDGF receptor expression on cells of the endometrium 
is not known. It is an interesting possibility, which remains 
to be investigated, that the PDGF receptor levels are steroid 
hormone-dependent. 
The  presence  of receptor  staining  on  the  proliferating 
(coiled-like) arteries of the endometrium, but not on larger 
blood vessels in the myometrium, is  in  keeping with our 
previous  observations  in  rheumatoid  arthritic  synovium, 
where B type PDGF receptor staining was seen on proliferat- 
ing blood vessels in conjunction with the intense neovascu- 
larization seen in some forms of rheumatoid arthritis, but not 
in blood vessels from normal tissue (35). In addition, expres- 
sion of B type PDGF receptor mRNA was found in prolifer- 
ating endothelium of a human glioblastoma (21). These obser- 
vations suggest that PDGF receptor induction may play a role 
in neovascularization. 
A possible explanation for the lack of staining in the myo- 
metrium could be that the cells were so tightly packed that 
the antibody did not have access to the receptor. Evidence 
against this possibility includes the fact that the myometrium 
from a young animal, handled in the same way, did stain for 
the receptor. The finding of PDGF receptor expression in the 
myometrium of a young animal is intriguing. Together with 
the finding that other smooth muscle cell types, under certain 
conditions, produce PDGF-Iike factors (28, 36), it may sug- 
gest a role for PDGF-like factors in autocrine or paracrine 
stimulation of cell growth in the growing uterus. 
Interestingly, B type PDGF receptors appeared on certain 
Terracio et al. Induction of PDGF Receptor Expression  1955 cell types as they progressed and adapted to tissue culture 
conditions.  This  was  best  observed  in the porcine uterus 
smooth muscle where the cells could be seen to acquire the 
receptors over a 3-d period, but was also evident in human 
dermal  fibroblasts.  Once  the  receptors  could  be  demon- 
strated  by immunofluorescence,  they could be down-regu- 
lated by PDGF. Cells maintained and passaged in culture had 
receptors that would autophosphorylate in membrane prepa- 
ration. The lack of staining on freshly isolated cells appears 
to reflect the lack of receptor and not to be an artifact caused 
by the collagenase digestion, since endometrial cells isolated 
in the same way still possess the receptors (Fig. 4 b), and ex- 
posing  cultured  smooth  muscle  cells  to  the  collagenase 
digestion solution for up to 9  h did not eliminate receptor 
staining in these cells  (data not shown). 
An  alternative  explanation for  the  lack  of receptors  on 
freshly isolated smooth muscles cells is that local high con- 
centrations of PDGF in the tissue had caused the receptors 
to down-regulate. However, this possibility is unlikely, since 
only very high PDGF concentrations would produce such an 
efficient down-regulation, and since it takes only '~4 h for 
receptors to reappear on the cell surface of cultured cells af- 
ter PDGF has been removed from the cell culture medium 
(16), whereas the receptor does not appear on the cultured 
smooth muscle cells until after  18 h in culture. Thus, it ap- 
pears that tissue culturing induces an up-regulation of the 
receptor on these cells. The mechanism behind the receptor 
induction remains to be elucidated. It may involve humoral 
factors,  e.g.,  present  in  the  serum  added  to  the  culture 
medium.  In addition, the interruption of cell-cell and cell- 
matrix interactions may be important. 
Recent studies have revealed that human PDGF occurs in 
three isoforms,  PDGF-AA,  PDGF-AB and PDGF-BB,  that 
bind with different affinities to two separate receptor classes, 
denoted type A  and type B  (14,  20).  PDGF purified from 
porcine platelets was identified as PDGF-BB (37). However, 
porcine endothelial cells contain both PDGF A and B chain 
mRNA (Hammacher, A., K. Miyazono, B. Westermark, and 
C.-H. Heldin, unpublished observations), suggesting that all 
three  isoforms  of PDGF  occur  also  in pigs.  Our present 
studies  indicate  that porcine  cells  contain  B  type  PDGF 
receptors;  whether A  type receptors also occur in pigs, re- 
mains to be determined. 
The data from the present study indicates that the response 
of normal connective tissue cells to PDGF may be regulated, 
not only by the availability of the ligand, but also by the ex- 
pression of PDGF receptors at the cell  surface. 
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